IDEAYA Biosciences's market cap is currently ―. The company's EPS TTM is $-1.962; its P/E ratio is -20.46; IDEAYA Biosciences is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 3.92M	$ 3.54M	$ 7.88M	$ 4.02M	$ 29.70M
Gross Profit	$ 3.92M	$ 3.54M	$ 7.88M	$ 4.02M	-
EBIT	$ -33.95M	$ -27.93M	$ -23.64M	$ -26.44M	$ 660.00K
EBITDA	$ -36.81M	$ -29.48M	$ -24.24M	$ -27.54M	$ 1.58M
Net Income Common Stockholders	$ -33.95M	$ -27.93M	$ -23.64M	$ -24.20M	$ 1.61M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 525.11M	$ 493.72M	$ 339.47M	$ 364.83M	$ 386.24M
Total Assets	$ 649.32M	$ 527.56M	$ 364.75M	$ 387.97M	$ 410.91M
Total Debt	$ 2.87M	$ 2.57M	$ 3.03M	$ 3.48M	$ 3.92M
Net Debt	$ -522.24M	$ -491.14M	$ -336.44M	$ -361.35M	$ -382.32M
Total Liabilities	$ 28.23M	$ 25.95M	$ 30.94M	$ 38.51M	$ 42.14M
Stockholders Equity	$ 621.09M	$ 501.58M	$ 333.81M	$ 349.45M	$ 368.77M
Cash Flow	-
Free Cash Flow	$ -24.59M	$ -34.34M	$ -27.89M	$ -23.37M	$ -25.27M
Operating Cash Flow	$ -23.75M	$ -33.46M	$ -27.84M	$ -23.37M	$ -24.17M
Investing Cash Flow	$ -111.94M	$ -121.38M	$ 23.52M	$ -10.28M	$ -18.68M
Financing Cash Flow	$ 140.89M	$ 191.06M	$ 2.93M	$ 324.00K	$ 95.70M

Currency in USD

IDEAYA Biosciences Earnings and Revenue History

Income Statement >

IDEAYA Biosciences Debt to Assets

Balance Sheet >

IDEAYA Biosciences Cash Flow

Cash Flow >

IDEAYA Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing